echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Active Ingredient News
    Pancreatic cancer double immune + radiotherapy phase 2 trial achieved good results

    -label Phase 2 trial involving 324 patients with locally advanced rectal cancer with clinical stage II (T3-4, N0) or III (any T, N1-2); patients enrolled 1: 1 were randomized to receive induction chemotherapy followed by CRT (n=158) or CRT followed

    Coatings News
    PPG Completes Acquisition of Arsonsisi Powder Coatings Manufacturing Business

    PPG has completed the acquisition of the powder coatings manufacturing business of Arsonsisi, an industrial coatings company based in Milan, Italy .

    Biochemistry News
    Novartis Votrient safe and effective for patients with metastatic renal cell carcinoma!

    >. The drug was approved for marketing in the United States and the European Union in October 2009 and June 2010, respectively . Votrient was originally a product

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.